Low-dose belimumab reduced risk of flares in patients with systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial

Journal:
Annals of the Rheumatic Diseases
Published:
DOI:
10.1016/j.ard.2025.10.010
Affiliations:
4
Authors:
9
Institutions Authors Share
Renji Hospital, SJTU, China
7.000000
0.78
Huashan Hospital, Fudan University, China
1.000000
0.11
Shanghai Sixth People's Hospital, SJTU, China
1.000000
0.11